跳至主要内容
临床试验/IRCT201312031414N30
IRCT201312031414N30
已完成
4 期

Evaluation of Satisfaction and Short-term Side effect after OsteoCalVitFort Practice in population whom use Calcium Supplement

pharmedshayan pharmaceutical0 个研究点目标入组 200 人待定

概览

阶段
4 期
干预措施
未指定
疾病 / 适应症
side effect of Calcium vitamin D.
发起方
pharmedshayan pharmaceutical
入组人数
200
状态
已完成
最后更新
8年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
8年前
研究类型
Interventional
性别
All

研究者

发起方
pharmedshayan pharmaceutical

入排标准

入选标准

  • Age between 45 to 70 years old who received Calcium supplement; In good health, as determined by the principal investigator based on medical history and physical examination; Clinical laboratory evaluations within the reference range for the test laboratory; Ability to comprehend and willingness to sign the Informed Consent Form for this study.
  • Exclusion criteria:
  • Clinically complicated biochemical tests; Any diagnosed malignancy; Any drug hypersensitivity; History of kidney stone; hyperparathyroidism or sarcoidosis; unwilling to participation.

排除标准

  • 未提供

结局指标

主要结局

未指定

相似试验